These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D. Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797 [Abstract] [Full Text] [Related]
5. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder. Katila H, Mezhebovsky I, Mulroy A, Berggren L, Eriksson H, Earley W, Datto C. Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397 [Abstract] [Full Text] [Related]
6. Quetiapine: a review of its use in the management of bipolar depression. Sanford M, Keating GM. CNS Drugs; 2012 May 01; 26(5):435-60. PubMed ID: 22519923 [Abstract] [Full Text] [Related]
8. Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder. Locklear JC, Svedsäter H, Datto C, Endicott J. J Affect Disord; 2013 Jul 01; 149(1-3):189-95. PubMed ID: 23639212 [Abstract] [Full Text] [Related]
9. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder. Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA. J Affect Disord; 2013 Oct 01; 151(1):209-19. PubMed ID: 23810357 [Abstract] [Full Text] [Related]
13. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial. Findling RL, Pathak S, Earley WR, Liu S, DelBello MP. J Child Adolesc Psychopharmacol; 2014 Aug 01; 24(6):325-35. PubMed ID: 24956042 [Abstract] [Full Text] [Related]
14. Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial. Gao K, Wu R, Kemp DE, Chen J, Karberg E, Conroy C, Chan P, Ren M, Serrano MB, Ganocy SJ, Calabrese JR. J Clin Psychiatry; 2014 Oct 01; 75(10):1062-8. PubMed ID: 25007003 [Abstract] [Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Calabrese JR, Keck PE, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J. Am J Psychiatry; 2005 Jul 01; 162(7):1351-60. PubMed ID: 15994719 [Abstract] [Full Text] [Related]